OmniCorder Receives 2005 Product Leadership Of The Year Award; Frost & Sullivan Recognizes Company’s Medical Imaging System For Cancer And Vascular Disease Diagnostics Markets

BOHEMIA, N. Y.--(BUSINESS WIRE)--March 16, 2005--OmniCorder Technologies, Inc. (OTCBB Symbol: OMCT) is pleased to announce that it has received Frost & Sullivan’s “2005 Medical Imaging in Cancer & Vascular Disease Diagnostics Product Leadership of the Year Award” for developing the BioScanIR(R) System. The award will be received by OmniCorder at the Frost & Sullivan 2005 Excellence in Medical Devices Awards Banquet taking place in San Francisco, CA. According to Michael Valenti, research analyst for Frost & Sullivan, “This award not only recognizes the innovative technology behind the product but also its strong market potential.”